YM BioSciences increases offering size to approximately US$17.5 million
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), today announced that the previously announced offering of approximately US…
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), today announced that the previously announced offering of approximately US…
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), today announced that it is raising approximately US$15 million in a "regis…
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announces that it filed a Form 6K describing that certain US patents for n…
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and…
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announced that the merger of Cytopia Limited, the Australian biopharmaceut…
YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a life sciences product development company that identifies and advances…
YM BioSciences Inc. (NYSE Alternext USA: YMI, TSX: YM, AIM: YMBA), ein Onkologie-Unternehmen, welches differenzierte Pro…
BBM Holdings (OTC Bulletin Board: BBMO - News) announced today that it has made an offer to acquire YM BioSciences Inc.…
YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes di…
YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), ein auf Onkologie fokussiertes Unternehmen, das differenzierte Prod…